Design Therapeutics (DSGN) Options Chain & Prices $13.37 +0.93 (+7.51%) As of 01:34 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DSGN Put and Call Options List 1/15/2027 12/18/2026 10/16/2026 8/21/2026 7/17/2026 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades7/17/2026$11.00$2.634Call2 - - 0(+0)137.24% (+2.31%)0.70163817/17/2026$13.00$1.540Call1010 - 3(+0)125.37% (-4.91%)0.52848517/17/2026$14.00$1.250Call20 - - 6(+0)129.34% (-7.00%)0.45152517/17/2026$15.00$1.065Call10 - 106(+4)136.18% (-7.94%)0.3915481End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Tarsus Pharmaceuticals Options Data IDEAYA Biosciences Options Data Enliven Therapeutics Options Data Ultragenyx Pharmaceutical Options Data Vera Therapeutics Options Data Kodiak Sciences Options Data Intellia Therapeutics Options Data Trevi Therapeutics Options Data Aurinia Pharmaceuticals Options Data Immunome Options Data Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:DSGN) was last updated on 6/22/2026 by MarketBeat.com Staff. From Our PartnersVWAV: One Defense Stock Worth WatchingVisionWave Holdings (NASDAQ: VWAV) is developing an integrated defense technology platform combining AI-driven...Smallcaps Daily | SponsoredTrump Is Eyeing the Biggest Monetary Shift Since NixonOn August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...Americas Gold Company | SponsoredThe U.S. Government Just Turned Tax Dollars1 into 407% GainsThe U.S. Government has quietly built a stock portfolio that's up 278% in less than nine months - 26 times bet...Weiss Ratings | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe gold strategy buried in Trump's plans that insiders are already watchingNancy Pelosi's portfolio gained 71 percent in 2024 while the S&P 500 returned just 28 percent. In 2023, she ea...American Alternative | SponsoredGold Is About to Do Something It Hasn’t in 90 YearsThe U.S. Treasury still carries America's gold reserves at $42 per ounce — a price set generations ago. Buried...US Gold Bureau | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredRead this before you touch SPCXSPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Design Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Design Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
